Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) just unveiled an announcement.
Shanghai Fosun Pharmaceutical has announced changes to its registered capital and articles of association following the cancellation of 897,140 restricted shares. This adjustment reduces the company’s total share capital and registered capital, reflecting a strategic move to optimize its capital structure. The changes have been approved by the board and align with the company’s ongoing efforts to enhance operational efficiency and shareholder value.
More about Shanghai Fosun Pharmaceutical (Group) Co
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company incorporated in China, operating in the pharmaceutical industry. The company focuses on the development, manufacturing, and distribution of pharmaceutical products, healthcare services, and medical devices, with a significant market presence in both domestic and international sectors.
Average Trading Volume: 5,768,336
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.95B
For detailed information about 2196 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue